Answers are grounded in this paper and cite their sources.
Randomized trial compares analgesic effects of ESPB and SAPB in patients with rib fractures, suggesting ESPB as a preferred technique.
Objective This large-sample, randomized, double-blind controlled trial directly compared the analgesic efficacy and impact on respiratory function of ultrasound-guided erector spinae plane block (ESPB) versus serratus anterior plane block (SAPB) in patients with unilateral multiple rib fractures. Methods A total of 158 eligible patients were randomized to receive either ESPB ( n = 73) or SAPB ( n = 85), performed with 0.375% ropivacaine. The primary outcome was the time-weighted area under the curve (AUC) of resting pain Numerical Rating Scale (NRS) scores over 24 h post-intervention. Secondary outcomes included dynamic pain scores, opioid consumption, respiratory function (diaphragmatic excursion, FVC, FEV1), recovery quality (QoR-15), and clinical outcomes. Results The ESPB group demonstrated a significantly lower 24-h pain AUC compared to the SAPB group (mean difference −17.78, 95% CI: −21.00 to −14.56, p < 0.001), indicating superior comprehensive analgesia. ESPB also significantly reduced 24-h opioid consumption and improved QoR-15 scores (both p < 0.01). While both groups showed significant within-group improvement in respiratory function parameters, no significant between-group differences were found. Subgroup analysis revealed that the analgesic superiority of ESPB was consistent across different fracture locations but was more pronounced in patients with ≤5 fractures (interaction p = 0.023). Safety profiles and complication rates were comparable. Conclusion For patients with unilateral multiple rib fractures, ESPB provides significantly better early comprehensive analgesia and reduces opioid requirements compared to SAPB, without compromising safety. ESPB may be considered as a preferred first-line regional analgesic technique, especially for patients with a lower fracture burden. Clinical trial registration Chinese Clinical Trial Registry (ChiCTR), Registration No. ChiCTR2300067544.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: